Long Noncoding RNA in Digestive Tract Cancers: Function, Mechanism, and Potential Biomarker

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Digestive tract cancers (DTCs) are a major global cause of cancer mortality.
• Current treatments for advanced DTCs are limited, and early diagnosis is hindered by a lack of effective biomarkers.
• There is a critical need for novel biomarkers for early detection and new therapeutic targets for DTCs.

Purpose of the Study:

• To review the role of long noncoding RNAs (lncRNAs) in the development and progression of digestive tract cancers.
• To summarize the functions and regulatory mechanisms of lncRNAs implicated in DTCs.
• To highlight the potential of lncRNAs as diagnostic biomarkers and therapeutic targets for DTCs.

Main Methods:

• Literature review focusing on studies investigating lncRNAs in digestive tract cancers.
• Analysis of research on the aberrant expression of lncRNAs in DTCs.
• Examination of the oncogenic and tumor-suppressive roles of lncRNAs in DTC progression.

Main Results:

• lncRNAs are frequently aberrantly expressed in DTCs.
• lncRNA expression profiles correlate with poor patient survival in DTCs.
• lncRNAs function as either oncogenes or tumor suppressor genes in DTCs.

Conclusions:

• lncRNAs play significant roles in the pathogenesis of digestive tract cancers.
• lncRNAs represent promising candidates for early diagnostic biomarkers and therapeutic targets in DTCs.
• Further research into lncRNA regulatory mechanisms is warranted for advancing DTC treatment strategies.